A Matter of General Interest Perhaps...

[Dmactds]

This just made the news here:

fiercepharma.com/story/glax...

FDA nod for blockbuster COPD hopeful Anoro Ellipta

"...GlaxoSmithKline's ($GSK) respiratory franchise got a boost from the FDA Wednesday, and not a moment too soon. The agency green-lighted its COPD treatment Anoro Ellipta just as a generic of Glaxo's top-selling Advair won its first approval--a reminder that competition for the lung giant may be just around the corner.

According to GSK, Anoro now becomes the first once-daily COPD treatment in the U.S. to combine two drugs that relax airways in a single inhaler. And that's a coup; Anoro beat out treatments still in development at companies like Novartis ($NVS) and Forest Labs ($FRX). Partner Theravance ($THRX) will now turn over a $30 million milestone payment to Glaxo, with another $30 million scheduled for after Anoro's U.S. launch; Glaxo says it plans to begin the rollout early next year..."

[Dmactds]

Yes..., docs of various stripes have been telling me I have COPD for several years; it's only in the last couple of years that it's gotten a bit more difficult. Had a pulmonary collapse of sorts 16 mos ago and that took awhile to get over and come to terms with; I'm still not the person I was 7 years or so ago but I'm not infirm either. Walking can be a chore, even more so in the summer (I'm in the humid, hot southern area of the country..)

All one can do is simply: "KEEP ON TRUCKIN' "!!!!

[CornishBrian]

That looks promising. I did used to have a god inhaler that kept things under control "Combivent" but it was withdrawn because they couldn't manufacture a CFC version of it. It took a couple of years swapping and trying different combinations of inhalers before things returned to normal.

[onamission]

This is fantastic news I wonder if this one has the steroid in it and I wonder how long we will have to wait till GPs start prescribing it.